- Dollar Amount of Shares Sold
- $26,202,050.70
- Number of Insider Stock Sales in the Last 180 Days
- 19
- Volume of Shares Sold
- 598,456
- Who Sold Shares
- Amy C Peterson (CMO), Bob Oliver (Director), Christopher J Senner (CFO), Dana Aftab (EVP), George Poste (Director), Jack L Wyszomierski (Director), Jeffrey Hessekiel (EVP), Mary C Beckerle (Director), Patrick J Haley (EVP), Stelios Papadopoulos (Director), Sue Gail Eckhardt (Director) and Tomas J Heyman (Director)
About Exelixis
Exelixis, Inc, an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer.
More about Exelixis
